Related references
Note: Only part of the references are listed.Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Flavia Alves Verza et al.
CANCERS (2020)
Chemopreventive Property of Sencha Tea Extracts towards Sensitive and Multidrug-Resistant Leukemia and Multiple Myeloma Cells
Xiaohua Lu et al.
BIOMOLECULES (2020)
Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells
Mona Dawood et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344
Mona Dawood et al.
PHARMACOLOGICAL RESEARCH (2020)
Putative molecular determinants mediating sensitivity or resistance towards carnosic acid tumor cell responses
Nuha Mahmoud et al.
PHYTOMEDICINE (2020)
Swiss Target Prediction: updated data and new features for efficient prediction of protein targets of small molecules
Antoine Daina et al.
NUCLEIC ACIDS RESEARCH (2019)
Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
Mona Dawood et al.
FRONTIERS IN PHARMACOLOGY (2019)
Natural products as multidrug resistance modulators in cancer
Amit Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines
Francesco Mararnpon et al.
CANCER LETTERS (2019)
CDK9 inhibitors in acute myeloid leukemia
Silvia Boffo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology
Mona Dawood et al.
FRONTIERS IN PHARMACOLOGY (2018)
Zebrafish: Speeding Up the Cancer Drug Discovery Process
Patricia Letrado et al.
CANCER RESEARCH (2018)
Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation
Nuha Mahmoud et al.
Oncotarget (2018)
The role of p53 in cancer drug resistance and targeted chemotherapy
Karin Hientz et al.
ONCOTARGET (2017)
The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer
Fabio Ciccarone et al.
SEMINARS IN CANCER BIOLOGY (2017)
被撤回的出版物: miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10 (Retracted article. See vol. 28, pg. 591, 2022)
Bowen Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway
Hsien-Chuen Soo et al.
PLOS ONE (2017)
Carnosic acid induces apoptosis of hepatocellular carcinoma cells via ROS-mediated mitochondrial pathway
Xinrui Zhang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
Hyun-Wook Ryu et al.
CANCER LETTERS (2017)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients
Cinzia Pellegrini et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Mechanistic diversity in ATP-binding cassette (ABC) transporters
Kaspar P. Locher
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Histone Modifications and Cancer
James E. Audia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Mechanistic diversity in ATP-binding cassette (ABC) transporters
Kaspar P. Locher
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
Y. Shi et al.
ANNALS OF ONCOLOGY (2015)
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Hyon-Zu Lee et al.
CLINICAL CANCER RESEARCH (2015)
The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf-1 and Non-Canonical Wnt Signaling
Oncotarget (2015)
Reverse docking: a powerful tool for drug repositioning and drug rescue
Prashant S. Kharkar et al.
FUTURE MEDICINAL CHEMISTRY (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
David Gfeller et al.
NUCLEIC ACIDS RESEARCH (2014)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
Berit Maria Mueller et al.
BMC CANCER (2013)
Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance
D. Dupere-Richer et al.
CELL DEATH & DISEASE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Xuan-Yu Meng et al.
Current Computer-Aided Drug Design (2012)
Molecular Interaction Studies Using Microscale Thermophoresis
Moran Jerabek-Willemsen et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2011)
Molecular docking and pharmacogenomics of Vinca alkaloids and their monomeric precursors, vindoline and catharanthine
Serkan Sertel et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Chipster: user-friendly analysis software for microarray and other high-throughput data
M. Aleksi Kallio et al.
BMC GENOMICS (2011)
Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
Mario Federico et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer
Kathrin Mutze et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Clinical Toxicities of Histone Deacetylase Inhibitors
Srividya Subramanian et al.
PHARMACEUTICALS (2010)
HDAC expression and clinical prognosis in human malignancies
Wilko Weichert
CANCER LETTERS (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Bioinformatics applications for pathway analysis of microarray data
Thomas Werner
CURRENT OPINION IN BIOTECHNOLOGY (2008)
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
Madeleine Duvic et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Mitochondria, oxidative stress and cell death
Martin Ott et al.
APOPTOSIS (2007)
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma, (CTCL)
Madeleine Duvic et al.
BLOOD (2007)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
NY Frank et al.
CANCER RESEARCH (2005)
Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes
JP Gillet et al.
CANCER RESEARCH (2004)
Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter
NY Frank et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
LA Doyle et al.
ONCOGENE (2003)
Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes
F de Longueville et al.
TOXICOLOGICAL SCIENCES (2003)
Molecular modes of action of artesunate in tumor cell lines
T Efferth et al.
MOLECULAR PHARMACOLOGY (2003)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
Role of reactive oxygen species (ROS) in apoptosis induction
HU Simon et al.
APOPTOSIS (2000)
Share Paper
